Argitalpenak (14) MARTA ALONSO PEÑA argitalpenak

2023

  1. Clinical simulation in health education: a systematic review

    Investigacion y Educacion en Enfermeria, Vol. 41, Núm. 2

  2. Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key

    International Journal of Molecular Sciences, Vol. 24, Núm. 13

  3. The Cantabria Cohort, a protocol for a population-based cohort in northern Spain

    BMC Public Health, Vol. 23, Núm. 1

2022

  1. Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia

    Hepatology, Vol. 76, Núm. 5, pp. 1259-1274

  2. Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation

    Cells, Vol. 11, Núm. 24

  3. Pathophysiological mechanisms in non-alcoholic fatty liver disease: From drivers to targets

    Biomedicines, Vol. 10, Núm. 1

2021

  1. Immune assessment of BNT162b2 m-RNA-spike based vaccine response in adults

    Biomedicines, Vol. 9, Núm. 8

  2. Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity

    Frontiers in Immunology, Vol. 12

  3. Innate and adaptive immune assessment at admission to predict clinical outcome in covid-19 patients

    Biomedicines, Vol. 9, Núm. 8

  4. Myeloid-Derived Suppressor Cells Are Increased in Lung Transplant Recipients and Regulated by Immunosuppressive Therapy

    Frontiers in Immunology, Vol. 12

2019

  1. Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy

    Hepatology, Vol. 70, Núm. 4, pp. 1246-1261

  2. Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma

    Cancer Drug Resistance, Vol. 2, Núm. 3, pp. 680-709

  3. Role of transportome in the pharmacogenomics of hepatocellular carcinoma and hepatobiliary cancer

    Pharmacogenomics, Vol. 20, Núm. 13, pp. 957-970

2017

  1. ACOX2 deficiency: An inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia

    Journal of Hepatology, Vol. 66, Núm. 3, pp. 581-588